Clinical trial

Treating PCOS With Semaglutide vs Active Lifestyle Intervention

NCT03919929

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-03

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2019-05-03Date precision: day

Registry last updated2025-11-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PCOSunresolved

Adolescent Obesityunresolved

NAFLDunresolved

Interventions

Semaglutide 3mg and 7mg [Rybelsus]DRUG

Weight loss dietOTHER

Sponsors & collaborators

University of Colorado, Denverlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03919929 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.